Komori
Daito Pharmaceutical (4577) · RiskFirst stated

Extreme Weather and Business Impact Risks from Climate Change

First written in FY2022. . Latest entry: FY2022.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Physical, transition and reputational risks associated with climate changeA theme 160 companies write about · 160 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2020: 1 of 12 companies on the "Worse" side.

26 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 160 companies compared. The sentences above are computed from all 160.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Daito Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Extreme Weather and Business Impact Risks from Climate Change | Daito Pharmaceutical Co.,Ltd. (4577) | Komori